Completed PHASE3 INTERVENTIONAL 2-arm NCT01153594

Early Re-Intervention Experiment 2 (ERI2)

Early Re-Intervention (ERI) Experiment 2

Sponsor: Chestnut Health Systems

Interventions Recovery Management Checkups (RMC)

Updated 4 times since 2017 Last updated: Jun 29, 2010 Started: Feb 29, 2004 Primary completion: Jun 30, 2008 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Substance Use Disorders, this trial is completed. The trial is conducted by Chestnut Health Systems and has accumulated 4 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chestnut Health Systems
National Institute on Drug Abuse (NIDA)

Data source: Chestnut Health Systems

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States